Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cara Therapeutics 400 ATLANTIC STREET SUITE 500 STAMFORD CT 06901 USA

www.caratherapeutics.com Employees: 55 P: 203-406-3700

Description:

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

Key Statistics

Overview:

Market Capitalization, $K 23,182
Enterprise Value, $K -28,998
Shares Outstanding, K 54,856
Annual Sales, $ 20,970 K
Annual Net Income, $ -118,510 K
Last Quarter Sales, $ 2,560 K
Last Quarter Net Income, $ -12,480 K
EBIT, $ -85,580 K
EBITDA, $ -83,650 K
60-Month Beta 0.64
% of Insider Shareholders 3.10%
% of Institutional Shareholders 44.66%
Float, K 53,155
% Float 96.90%
Short Volume Ratio 0.39

Growth:

1-Year Return -30.34%
3-Year Return -96.66%
5-Year Return -97.46%
5-Year Revenue Growth 55.68%
5-Year Earnings Growth -6.31%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.15 on 11/14/24
Next Earnings Date 11/18/24
Earnings Per Share ttm -1.67
EPS Growth vs. Prev Qtr 59.46%
EPS Growth vs. Prev Year 71.15%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CARA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -367.97%
Return-on-Assets % -107.43%
Profit Margin % -565.14%
Debt/Equity 0.00
Price/Sales 1.07
Price/Cash Flow N/A
Price/Book 31.72
Book Value/Share 0.01
Interest Coverage -3.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar